Alpha-Synuclein Neuronal Uptake

Overview

flowchart TD
    Alpha_Synuclein_Neuronal_Uptak["Alpha-Synuclein Neuronal Uptake"]
    Alpha_Synuclein_Neuronal_Uptak["Alpha-Synuclein"]
    Alpha_Synuclein_Neuronal_Uptak -->|"related to"| Alpha_Synuclein_Neuronal_Uptak
    style Alpha_Synuclein_Neuronal_Uptak fill:#81c784,stroke:#333,color:#000
    Alpha_Synuclein_Neuronal_Uptak["extracellular"]
    Alpha_Synuclein_Neuronal_Uptak -->|"related to"| Alpha_Synuclein_Neuronal_Uptak
    style Alpha_Synuclein_Neuronal_Uptak fill:#81c784,stroke:#333,color:#000
    Alpha_Synuclein_Neuronal_Uptak["neurons"]
    Alpha_Synuclein_Neuronal_Uptak -->|"related to"| Alpha_Synuclein_Neuronal_Uptak
    style Alpha_Synuclein_Neuronal_Uptak fill:#81c784,stroke:#333,color:#000
    style Alpha_Synuclein_Neuronal_Uptak fill:#4fc3f7,stroke:#333,color:#000

The uptake of extracellular alpha-synuclein by neurons is a critical step in the prion-like propagation of pathology in Parkinson’s disease. Multiple uptake mechanisms have been identified, including endocytosis, macropinocytosis, and receptor-mediated uptake. Understanding these pathways is essential for developing therapies that can block the spread of pathology and for interpreting biomarker data from cerebrospinal fluid and blood.

Uptake Mechanisms

Receptor-Mediated Endocytosis

Several receptors have been implicated in alpha-synuclein uptake:

Lymphocyte-Activation Gene 3 (LAG3): LAG3 was identified as a specific receptor for alpha-synuclein aggregates ^{1Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 32016 · PMID 27708076Open reference}(https://pubmed.ncbi.nlm.nih.gov/27708076/). LAG3 preferentially binds oligomeric and fibrillar forms of alpha-synuclein, enabling selective uptake of pathological species:

• High-affinity binding to alpha-synuclein aggregates

• Internalization via clathrin-dependent mechanisms

• Blocking LAG3 reduces uptake and propagation in cellular models

• LAG3 is expressed in neurons, particularly in the substantia nigra

Other Potential Receptors:

• Toll-Like Receptors (TLR2, TLR4): May recognize alpha-synuclein as a damage-associated molecular pattern

• Prion Protein (PrP): Some evidence for interaction with alpha-synuclein

• Cell Adhesion Molecules: May facilitate uptake at synapses

Clathrin-Dependent Endocytosis

Classical clathrin-mediated endocytosis represents a major pathway for alpha-synuclein uptake:

1. Membrane Invagination: Alpha-synuclein binds to receptors, initiating clathrin pit formation

2. Coat Assembly: Clathrin triskelions assemble around the forming vesicle

3. Dynamin-Mediated Scission: GTP hydrolysis by dynamin releases the vesicle

4. Uncoating: Clathrin coat is removed, releasing the cargo for trafficking

Dynamin inhibition significantly reduces alpha-synuclein uptake, confirming the role of this pathway ^{2Distinct membrane binding and uptake mechanisms of alpha-synuclein oligomers and fibrils2021 · PMID 34056823Open reference}(https://pubmed.ncbi.nlm.nih.gov/34056823/).

Caveolin-Dependent Endocytosis

Caveolae represent an alternative entry point:

• Caveolae Structure: Flavin-containing flask-shaped invaginations

• Role in Neuronal Uptake: May contribute to uptake in specific neuronal populations

• Cargo Specificity: May preferentially internalize certain alpha-synuclein species

Macropinocytosis

Large-scale fluid-phase uptake can also mediate alpha-synuclein entry:

Activation: Growth factors, cellular stress, and certain proteins trigger macropinocytosis

Process: Membrane ruffling and closure forms large vesicles (0.2-5 μm) called macropinosomes

Uptake: Nonselective capture of extracellular fluid and any solutes present

Inflammatory signals may promote macropinocytic uptake of alpha-synuclein, particularly in microglia and infiltrating immune cells ^{3Macropinocytosis contributes to cellular uptake of alpha-synuclein2022 · PMID 36218561Open reference}(https://pubmed.ncbi.nlm.nih.gov/36218561/).

Direct Membrane Permeabilization

Alpha-synuclein oligomers can directly permeabilize membranes:

• Pore Formation: Oligomeric species form ion channels in the plasma membrane

• Channel-Mediated Entry: May allow direct passage of monomers into the cytoplasm

• Subunit Exchange: May enable direct transfer of alpha-synuclein between cells at points of contact

Cell-Type Specific Uptake

Neuronal Uptake

Neurons are the primary targets for pathological alpha-synuclein uptake:

Substantia Nigra Dopaminergic Neurons: High susceptibility to uptake and subsequent pathology:

• High expression of LAG3

• Extensive axonal arborization increasing exposure

• Metabolic vulnerability amplifies toxicity

Cortical Neurons: Involved in later stages of disease progression:

• Lower basal uptake rates

• Different receptor expression patterns

Interneurons: May serve as early propagation vectors

Glial Uptake

Glial cells also take up alpha-synuclein:

Microglia: Professional phagocytes that clear extracellular alpha-synuclein:

• High uptake capacity through phagocytosis and endocytosis

• May spread pathology to other cells

• Inflammatory activation affects uptake kinetics

Astrocytes: May take up and process alpha-synuclein:

• Potential for trans-astrocytic transport

• May contribute to propagation via end-feet

Intracellular Trafficking

Endosomal Processing

After internalization, alpha-synuclein follows the endocytic pathway:

1. Early Endosomes: Initial sorting compartment

2. Late Endosomes/Multivesicular Bodies: Acidification and cargo sorting

3. Lysosomes: Degradation destination for some species

4. Recycling Endosomes: Return to the surface or delivery to other compartments

Endosomal Escape

For templated conversion to occur, alpha-synuclein must escape the endosome:

• Endosomal Membrane Permeabilization: Caused by oligomeric alpha-synuclein

• pH-Dependent Release: Acidic endosomal pH may promote release

• ESCRT-Mediated Trafficking: May deliver seeds to the cytoplasm

Failed endosomal escape may target alpha-synuclein to lysosomal degradation, while successful escape enables cytoplasmic templated conversion ^{4Endosomal trafficking and release of internalized alpha-synuclein2022 · PMID 35728044Open reference}(https://pubmed.ncbi.nlm.nih.gov/35728044/).

Implications for Templated Conversion

The endosomal compartment may serve as a protected environment for templated conversion:

• Endosomal membranes may catalyze conformational changes

• Local concentration of endogenous alpha-synuclein in endosomes

• Spatial separation from cytoplasmic quality control systems

Factors Affecting Uptake

Alpha-Synuclein Properties

Oligomeric State: Oligomers and fibrils are taken up more efficiently than monomers:

• Higher affinity for receptors

• More potent activators of macropinocytosis

Post-Translational Modifications:

• Phosphorylation (pS129) enhances uptake

• Nitration increases binding to receptors

Strain Properties: Different strains exhibit different uptake efficiencies

Cellular Properties

Receptor Expression: LAG3 and other receptor levels determine uptake capacity

Endocytic Capacity: Activity of clathrin-mediated and other pathways

Cellular Stress: Stress conditions may increase uptake through multiple mechanisms

Therapeutic Implications

Blocking Uptake

Inhibiting neuronal uptake could halt pathology propagation:

• LAG3 Antagonists: Antibodies or small molecules blocking LAG3

• Receptor Downregulation: Reducing surface receptor expression

• Dynamin Inhibitors: Blocking clathrin-mediated endocytosis (caution: effects on normal endocytosis)

Modulating Endocytic Pathways

Targeting downstream trafficking:

• Endosomal Acidification: Inhibiting endosomal maturation

• ESCRT Modulation: Affecting endosomal sorting

Antibody-Mediated Blocking

Immunotherapy approaches to block uptake:

• Antibody Binding: Antibodies bound to extracellular alpha-synuclein may prevent receptor interactions

• Fc Receptor Effects: Antibody-opsonized alpha-synuclein may be differentially cleared ^{5Fc gamma receptor-mediated clearance of antibody-opsonized alpha-synuclein2023 · PMID 37279476Open reference}(https://pubmed.ncbi.nlm.nih.gov/37279476/)

Biomarker Implications

CSF Uptake Markers

Understanding uptake informs biomarker interpretation:

• Free alpha-synuclein in CSF may represent different pools than exosome-associated

• Seeding activity reflects uptake-competent species in the CSF

Blood-Brain Barrier Considerations

Peripheral and CNS compartments interact:

• Blood-derived alpha-synuclein may enter the CNS through uptake mechanisms

• Peripheral uptake into neurons is limited by the blood-brain barrier

See Also

• Synuclein Pathway in Parkinson’s Disease

• Alpha-Synuclein Prion-Like Spreading

• Alpha-Synuclein Seeding Kinetics

• Alpha-Synuclein Exosomal Secretion

• Tunneling Nanotubes for Alpha-Synuclein Transfer